DOID:3350: Difference between revisions

Latest revision as of 16:50, 12 September 2014

mesenchymal cell neoplasm

Namespace:

FANTOM

Definition:

"A cell type cancer that has_material_basis_in abnormally proliferating cells derived_from embryonic connective tissue that is capable of developing into connective tissue, such as bone, and cartilage, the lymphatic system, and the circulatory system." [url:http://en.wikipedia.org/wiki/Mesenchymal_cell, url:http://www.ncbi.nlm.nih.gov/books/NBK9549/]

Xrefs:

Expandlinks:

Synonyms:

"benign miscellaneous mesenchymal tumor" EXACT []
"mesenchymal tumor" EXACT [NCI2004_11_17:C7059]

Alt_id:

DOID:1630

Ontology association Each term has an is_a parent in the Disease Ontology, which has a linkage to an another entity and FANTOM5 samples.Libraries were grouped into mutually exclusive facets according to the FANTOM5 sample ontology mapping to DISEASE ontologies. link to ontology dataset data

Parents

is_a:	DOID:0050687(cell type cancer)

Children

is a:	FF:10778-110G4 (hepatic mesenchymal tumor cell line:LI90),DOID:6193 (epithelioid sarcoma)

Ontology Tree: Loaded from BioPortal

Ontorolgy tree(Small window open)

FF samples

Human (Homo sapiens)

10443-106F2 (epithelioid sarcoma cell line:HS-ES-1)
10495-107B9 (epithelioid sarcoma cell line:HS-ES-2R)
10778-110G4 (hepatic mesenchymal tumor cell line:LI90)

Mouse (Mus musculus)

10443-106F2 (epithelioid sarcoma cell line:HS-ES-1)
10495-107B9 (epithelioid sarcoma cell line:HS-ES-2R)
10778-110G4 (hepatic mesenchymal tumor cell line:LI90)

Enrichment analysis: top 100 FFCP enriched with this ontology termTOP 100 FANTOM5 Cage Peaks enriched with DOID:3350 (mesenchymal cell neoplasm), sorted by p-values Analyst: Hideya Kawaji link to source dataset human : data mouse : data

Show entries

Search:

P-value	FFCP	Short description
1.55e-98	FFCP PHASE2:Hg19::chr21:32526965..32526979,-	p@chr21:32526965..32526979, -
1.55e-98	FFCP PHASE1:Hg19::chr21:32526965..32526979,-	p@chr21:32526965..32526979, -
1.55e-98	FFCP PHASE2:Hg19::chr4:183750430..183750442,+	p@chr4:183750430..183750442, +
1.55e-98	FFCP PHASE1:Hg19::chr4:183750430..183750442,+	p@chr4:183750430..183750442, +
1.55e-98	FFCP PHASE2:Hg19::chr17:8774055..8774068,-	p@chr17:8774055..8774068, -
1.55e-98	FFCP PHASE1:Hg19::chr17:8774055..8774068,-	p@chr17:8774055..8774068, -
1.55e-98	FFCP PHASE2:Hg19::chr10:125605888..125605891,-	p@chr10:125605888..125605891, -
1.55e-98	FFCP PHASE1:Hg19::chr1:240319887..240319892,+	p@chr1:240319887..240319892, +
1.55e-98	FFCP PHASE2:Hg19::chr8:69961533..69961540,+	p@chr8:69961533..69961540, +
1.55e-98	FFCP PHASE1:Hg19::chr8:69961533..69961540,+	p@chr8:69961533..69961540, +
1.55e-98	FFCP PHASE1:Hg19::chr19:54545670..54545677,-	p@chr19:54545670..54545677, -
1.55e-98	FFCP PHASE2:Hg19::chr4:183750467..183750481,+	p@chr4:183750467..183750481, +
1.55e-98	FFCP PHASE1:Hg19::chr4:183750467..183750481,+	p@chr4:183750467..183750481, +
1.55e-98	FFCP PHASE2:Hg19::chr2:178887106..178887129,+	p@chr2:178887106..178887129, +
1.55e-98	FFCP PHASE1:Hg19::chr13:27202938..27202944,-	p@chr13:27202938..27202944, -
1.55e-98	FFCP PHASE2:Hg19::chr1:240319887..240319892,+	p@chr1:240319887..240319892, +
1.55e-98	FFCP PHASE1:Hg19::chr2:178887106..178887129,+	p@chr2:178887106..178887129, +
1.55e-98	FFCP PHASE1:Hg19::chr3:36170472..36170478,-	p@chr3:36170472..36170478, -
1.55e-98	FFCP PHASE2:Hg19::chr19:54545670..54545677,-	p@chr19:54545670..54545677, -
1.55e-98	FFCP PHASE1:Hg19::chr6:142429681..142429688,-	p@chr6:142429681..142429688, -
1.55e-98	FFCP PHASE2:Hg19::chr6:142429681..142429688,-	p@chr6:142429681..142429688, -
1.55e-98	FFCP PHASE2:Hg19::chr8:69961543..69961549,+	p@chr8:69961543..69961549, +
1.55e-98	FFCP PHASE1:Hg19::chr8:69961543..69961549,+	p@chr8:69961543..69961549, +
1.55e-98	FFCP PHASE1:Hg19::chr3:40101288..40101291,-	p@chr3:40101288..40101291, -
1.55e-98	FFCP PHASE1:Hg19::chr7:157478953..157478987,-	p@chr7:157478953..157478987, -
1.55e-98	FFCP PHASE2:Hg19::chr3:36170472..36170478,-	p@chr3:36170472..36170478, -
1.55e-98	FFCP PHASE1:Hg19::chr19:54598154..54598171,+	p@chr19:54598154..54598171, +
1.55e-98	FFCP PHASE2:Hg19::chr9:26171424..26171462,-	p@chr9:26171424..26171462, -
1.55e-98	FFCP PHASE1:Hg19::chr9:26171424..26171462,-	p@chr9:26171424..26171462, -
1.55e-98	FFCP PHASE1:Hg19::chr3:36170751..36170761,-	p@chr3:36170751..36170761, -
1.55e-98	FFCP PHASE2:Hg19::chr3:40101288..40101291,-	p@chr3:40101288..40101291, -
1.55e-98	FFCP PHASE2:Hg19::chr7:157478953..157478987,-	p@chr7:157478953..157478987, -
1.55e-98	FFCP PHASE1:Hg19::chr10:125605888..125605891,-	p@chr10:125605888..125605891, -
1.55e-98	FFCP PHASE2:Hg19::chr19:54598154..54598171,+	p@chr19:54598154..54598171, +
1.55e-98	FFCP PHASE2:Hg19::chr5:142023729..142023736,-	p26@FGF1
1.55e-98	FFCP PHASE2:Hg19::chr18:43282521..43282533,-	p@chr18:43282521..43282533, -
1.55e-98	FFCP PHASE1:Hg19::chr5:142023729..142023736,-	p26@FGF1
1.55e-98	FFCP PHASE1:Hg19::chr18:43282521..43282533,-	p@chr18:43282521..43282533, -
1.55e-98	FFCP PHASE2:Hg19::chr3:36170751..36170761,-	p@chr3:36170751..36170761, -
1.55e-98	FFCP PHASE1:Hg19::chr3:36170775..36170785,-	p@chr3:36170775..36170785, -
1.55e-98	FFCP PHASE2:Hg19::chr13:27202938..27202944,-	p@chr13:27202938..27202944, -
1.55e-98	FFCP PHASE2:Hg19::chr3:36170775..36170785,-	p@chr3:36170775..36170785, -
2.74e-50	FFCP PHASE2:Hg19::chr2:172271476..172271479,+	p@chr2:172271476..172271479, +
2.74e-50	FFCP PHASE1:Hg19::chr2:172271476..172271479,+	p@chr2:172271476..172271479, +
2.74e-50	FFCP PHASE1:Hg19::chr19:54545613..54545621,-	p@chr19:54545613..54545621, -
2.74e-50	FFCP PHASE2:Hg19::chr19:54545780..54545792,-	p@chr19:54545780..54545792, -
2.74e-50	FFCP PHASE2:Hg19::chr19:54545613..54545621,-	p@chr19:54545613..54545621, -
2.74e-50	FFCP PHASE2:Hg19::chr21:32529607..32529639,-	p@chr21:32529607..32529639, -
2.74e-50	FFCP PHASE1:Hg19::chr21:32529607..32529639,-	p@chr21:32529607..32529639, -
2.74e-50	FFCP PHASE2:Hg19::chr2:173955327..173955334,+	p26@ZAK
2.74e-50	FFCP PHASE1:Hg19::chr2:173955327..173955334,+	p26@ZAK
2.74e-50	FFCP PHASE2:Hg19::chr11:89114727..89114730,+	p@chr11:89114727..89114730, +
2.74e-50	FFCP PHASE1:Hg19::chr8:100957024..100957046,+	p@chr8:100957024..100957046, +
2.74e-50	FFCP PHASE2:Hg19::chr17:8774126..8774143,-	p@chr17:8774126..8774143, -
2.74e-50	FFCP PHASE1:Hg19::chr17:8774126..8774143,-	p@chr17:8774126..8774143, -
2.74e-50	FFCP PHASE1:Hg19::chr1:240320047..240320058,+	p@chr1:240320047..240320058, +
2.74e-50	FFCP PHASE2:Hg19::chr11:106426627..106426632,+	p@chr11:106426627..106426632, +
2.74e-50	FFCP PHASE1:Hg19::chr3:153575775..153575789,+	p@chr3:153575775..153575789, +
2.74e-50	FFCP PHASE2:Hg19::chr8:100957024..100957046,+	p@chr8:100957024..100957046, +
2.74e-50	FFCP PHASE1:Hg19::chr19:54545692..54545704,-	p@chr19:54545692..54545704, -
2.74e-50	FFCP PHASE2:Hg19::chr1:240320047..240320058,+	p@chr1:240320047..240320058, +
2.74e-50	FFCP PHASE2:Hg19::chr3:153575775..153575789,+	p@chr3:153575775..153575789, +
2.74e-50	FFCP PHASE2:Hg19::chr19:54545692..54545704,-	p@chr19:54545692..54545704, -
2.74e-50	FFCP PHASE1:Hg19::chr1:233860255..233860261,+	p2@BC032032
2.74e-50	FFCP PHASE2:Hg19::chr8:69961573..69961578,+	p@chr8:69961573..69961578, +
2.74e-50	FFCP PHASE1:Hg19::chr8:69961573..69961578,+	p@chr8:69961573..69961578, +
2.74e-50	FFCP PHASE2:Hg19::chr17:40477088..40477101,-	p24@STAT3
2.74e-50	FFCP PHASE1:Hg19::chr17:40477088..40477101,-	p24@STAT3
2.74e-50	FFCP PHASE1:Hg19::chr11:89114727..89114730,+	p@chr11:89114727..89114730, +
2.74e-50	FFCP PHASE1:Hg19::chr7:80929708..80929725,+	p@chr7:80929708..80929725, +
2.74e-50	FFCP PHASE1:Hg19::chr19:54600897..54600899,+	p@chr19:54600897..54600899, +
2.74e-50	FFCP PHASE2:Hg19::chr1:233860255..233860261,+	p2@BC032032
2.74e-50	FFCP PHASE2:Hg19::chr18:56495029..56495073,+	p@chr18:56495029..56495073, +
2.74e-50	FFCP PHASE1:Hg19::chr18:56495029..56495073,+	p@chr18:56495029..56495073, +
2.74e-50	FFCP PHASE1:Hg19::chr19:54545780..54545792,-	p@chr19:54545780..54545792, -
2.74e-50	FFCP PHASE2:Hg19::chr7:80929708..80929725,+	p@chr7:80929708..80929725, +
2.74e-50	FFCP PHASE1:Hg19::chr11:106426627..106426632,+	p@chr11:106426627..106426632, +
2.74e-50	FFCP PHASE2:Hg19::chr19:54600897..54600899,+	p@chr19:54600897..54600899, +
2.74e-50	FFCP PHASE1:Hg19::chr8:41559667..41559679,-	p@chr8:41559667..41559679, -
2.74e-50	FFCP PHASE2:Hg19::chr8:41559667..41559679,-	p@chr8:41559667..41559679, -
4.52e-50	FFCP PHASE1:Hg19::chr19:38182936..38182940,-	p@chr19:38182936..38182940, -
4.52e-50	FFCP PHASE2:Hg19::chr19:38182936..38182940,-	p@chr19:38182936..38182940, -
4.52e-50	FFCP PHASE2:Hg19::chr21:16426559..16426566,-	p@chr21:16426559..16426566, -
4.52e-50	FFCP PHASE1:Hg19::chr21:16426559..16426566,-	p@chr21:16426559..16426566, -
4.52e-50	FFCP PHASE2:Hg19::chr9:21549553..21549570,-	p@chr9:21549553..21549570, -
4.52e-50	FFCP PHASE1:Hg19::chr9:21549553..21549570,-	p@chr9:21549553..21549570, -
4.52e-50	FFCP PHASE2:Hg19::chr13:38275506..38275512,-	p@chr13:38275506..38275512, -
4.52e-50	FFCP PHASE2:Hg19::chr18:56494810..56494816,-	p@chr18:56494810..56494816, -
4.52e-50	FFCP PHASE1:Hg19::chr18:56494810..56494816,-	p@chr18:56494810..56494816, -
4.52e-50	FFCP PHASE2:Hg19::chr13:38320384..38320418,-	p@chr13:38320384..38320418, -
4.52e-50	FFCP PHASE1:Hg19::chr6:2938437..2938442,-	p@chr6:2938437..2938442, -
4.52e-50	FFCP PHASE2:Hg19::chr18:61501808..61501812,+	p@chr18:61501808..61501812, +
4.52e-50	FFCP PHASE1:Hg19::chr18:61501808..61501812,+	p@chr18:61501808..61501812, +
4.52e-50	FFCP PHASE2:Hg19::chrX:135342362..135342373,+	p@chrX:135342362..135342373, +
4.52e-50	FFCP PHASE1:Hg19::chr13:38275506..38275512,-	p@chr13:38275506..38275512, -
4.52e-50	FFCP PHASE1:Hg19::chrX:135342362..135342373,+	p@chrX:135342362..135342373, +
4.52e-50	FFCP PHASE2:Hg19::chr5:57104911..57104918,-	p@chr5:57104911..57104918, -
4.52e-50	FFCP PHASE1:Hg19::chr5:57104911..57104918,-	p@chr5:57104911..57104918, -
4.52e-50	FFCP PHASE2:Hg19::chr6:2938437..2938442,-	p@chr6:2938437..2938442, -
4.52e-50	FFCP PHASE1:Hg19::chr13:38320384..38320418,-	p@chr13:38320384..38320418, -

Showing 1 to 100 of 100 entries

@@ Line 1: / Line 1: @@
 {{DOID
-|id=DOID:3350
+|alt_id=DOID:1630
-|name=mesenchymal cell neoplasm
-|namespace=
-|def="A cell type cancer that has_material_basis_in abnormally proliferating cells derived_from embryonic connective tissue that is capable of developing into connective tissue, such as bone, and cartilage, the lymphatic system, and the circulatory system." [url:http\://en.wikipedia.org/wiki/Mesenchymal_cell, url:http\://www.ncbi.nlm.nih.gov/books/NBK9549/]
-|xref=
-|is_a=DOID:0050687
-|synonym="benign miscellaneous mesenchymal tumor" EXACT [];;"mesenchymal tumor" EXACT [NCI2004_11_17:C7059]
 |comment=
-|alt_id=DOID:1630
-|disjoint_from=
-|union_of=
 |created_by=
-|obo_creation_date=
+|def="A cell type cancer that has_material_basis_in abnormally proliferating cells derived_from embryonic connective tissue that is capable of developing into connective tissue, such as bone, and cartilage, the lymphatic system, and the circulatory system." [url:http://en.wikipedia.org/wiki/Mesenchymal_cell, url:http://www.ncbi.nlm.nih.gov/books/NBK9549/]
-|subset=
-|adjacent_to=
 |derives_from=
 |develops_from=
+|disjoint_from=
 |has_quality=
+|id=DOID:3350
+|is_a=DOID:0050687
+|is_obsolete=
 |located_in=
+|name=mesenchymal cell neoplasm
+|namespace=FANTOM
+|obo_creation_date=
 |part_of=
+|preceded_by=
+|property_value=IAO:0000412 file:/Users/cjm/Dropbox/fantom5/HumanDO.obo
+|subset=
+|synonym="benign miscellaneous mesenchymal tumor" EXACT [];;"mesenchymal tumor" EXACT [NCI2004_11_17:C7059]
+|union_of=
+|xref=NCI:C6587;;UMLS_CUI:C1332517;;UMLS_CUI:C1334699
 }}

Personal tools

DOID:3350: Difference between revisions - resource_browser

Search

Human

Mouse

Rat

Dog

Chicken

Macaque

Cross species

Other

Tools

DOID:3350: Difference between revisions

From FANTOM5_SSTAR

Latest revision as of 16:50, 12 September 2014

Ontology Tree: Loaded from BioPortal

FF samples

	FAQ
	Mozilla Cavendish skin modified by DaSch for the Web Community Wiki GitHub project page – Report a bug – Skin version: 2.6.0